'Migraine Buddy increases patient engagement and helps patients become more cognizant of how migraine attacks start and how to treat them. It also allows patients to provide their physician with a summary of migraine symptoms, frequency, and previous treatments.'
Read MoreTogether with leading experts in neurology, telemedicine and digital, Novartis pilots an employee migraine support program with Healint to address the burden of migraine at workplace.
Read MoreHealint’s Head of Data at Echelon Singapore #echelon18
Read MoreLatest research featuring Migraine Buddy insights puts the cost of migraine to the economy in UK to £3.3 billion and in France to €3.8 billion a year
Read MoreHealint is please to join the Asia Pacific Medical Technology Association, APACMed, representing leading manufacturers and suppliers of medical equipment, devices and other key medical technology industry companies.
Read MoreHealint at American Headache Society’s 60th Annual Scientific Meeting in San Francisco, June 28, 2018
Read MoreLatest Migraine Buddy study presented at the 4th Congress of the European Academy of Neurology (EAN) in Lisbon shows migraines weigh heavily on careers, economies and budgets in Switzerland
Read MoreHealint, the developer of Migraine Buddy, the world’s largest migraine tracking and research platform, today announced data on the impact of migraine on work productivity, unveiled in a poster presentation at the Fourth Congress of the European Academy of Neurology (EAN) June 16-19, 2018.
Read MoreMigraine is a complex neurological condition. Valerie, 42, from Northeast Ohio shares what it is like to be living with it.
Read More